Innovate is key for us and this lead to the discovery of an FLT3 kinase inhibitor very selective and potent compare to benchmarker in clinical stage.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free